Microbiome Focused Seres Therapeutics Adds Experienced Biopharmaceutical Financial Leader to Board of Directors

Microbiome Focused Seres Therapeutics Adds Experienced Biopharmaceutical Financial Leader to Board of Directors

Submitted by admin on September 4, 2018 - 5:09pm
Source: 
CP WIre
News Tags: 
Seres Therapeutics
microbiome
Headline: 
Microbiome Focused Seres Therapeutics Adds Experienced Biopharmaceutical Financial Leader to Board of Directors
snippet: 

Seres Therapeutics, Inc. (Nasdaq:MCRB) today announced the appointment of Meryl Zausner, a seasoned biopharmaceutical executive, to its Board of Directors. Ms. Zausner brings decades of financial and operational leadership experience in the pharmaceutical industry.

Do Not Allow Advertisers to Use My Personal information